NRX Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Employees
- -
- Market Cap
- $21M
- Website
- http://www.nrxpharma.com
- Introduction
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.
No trials found
© Copyright 2024. All Rights Reserved by MedPath